000078.SZ
000078.SZ
CNE000000X95
NEPTUNUS
Loading chart...

Company Profile

-

Related stocks

002393.SZ
002393.SZ • China
LISHENGPHARMA
14.25 CNY
657.37M USD 1Y -26.5%
600351.SS
600351.SS • China
YABAO PHARMACEUTICAL GROUP CO L
7.07 CNY
732.07M USD 1Y +6.8%
300485.SZ
300485.SZ • China
SCIENCE SUN
8.57 CNY
617.67M USD 1Y -24%
600829.SS
600829.SS • China
HPGC RENMINTONGTAI PHARMACEUTIC
9.52 CNY
826.06M USD 1Y +19.9%
000915.SZ
000915.SZ • China
WIT DYNE
24.22 CNY
849.25M USD 1Y -23.8%
000566.SZ
000566.SZ • China
HAINAN HAIYAO
4.71 CNY
914.35M USD 1Y -13.7%
002390.SZ
002390.SZ • China
XINBANG PHAR.
3.01 CNY
875.5M USD 1Y -19.5%
300039.SZ
300039.SZ • China
SHANGHAI KAIBAO
5.39 CNY
843.62M USD 1Y -11.8%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
4 Metrics
Country
China
Region
Asia-Pacific
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
44.6% p.a.
Max Drawdown (5Y)
-75.6%
Sharpe Ratio (5Y)
-0.39
Beta Factor
-0.00
Size Class
Mid Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Critical leverage: Debt-to-Equity is at 550%.
Elevated Short-Term Volatility: 3Y volatility (52.2%) is noticeably higher than the 5Y average (44.6%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (44.6% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -82.0% in the extended horizon.
ende